Akzo Nobel (AKZA) AGM 2025 summary

Opening remarks and agenda

• Meeting opened by the Chair, with introductions of the Supervisory Board, Board of Management, and General Counsel.

• Voting procedures and participation guidelines explained, including in-person and virtual options.

• Record date set for voting eligibility; agenda and notes made available to attendees.

Financial performance review

• Achieved 1% organic volume growth and 2% organic sales growth in 2024, outperforming most competitors despite inflation and currency headwinds.

• Adjusted EBITDA increased by 3% to EUR 1.48 billion, with a margin of 14.1%.

• Return on investment improved to 13.3% in 2024; further improvements expected as asset utilization increases.

• Working capital challenges impacted cash generation, with corrective actions taken in Q4 to normalize inventory and payables.

• CapEx increased to support industrial transformation, with a three-year plan to invest EUR 350 million annually.

Board and executive committee updates

• Supervisory Board and Board of Management roles and changes highlighted, including retirements and new appointments.

• Remuneration policy updated, with adjustments to base salary and performance-related components for executives.